leisure time -WSS

leisure time

author：focus 2025-09-27 10:02:27 - browse：52979

Wraparound views of downtown Boston enrich the employees at the new offices of Foundation Medicine in the Seaport District. — Lane Turner/Globe Staff

Contemporary paintings by artists who have overcome homelessness or disabilities greet visitors in the lobby. Upstairs in the cafeteria, employees order lunches served by local restaurants, including barbecued pulled pork sandwiches from Pennypacker’s. On the top floor, workers can savor a panoramic view of the Seaport District and downtown Boston.

This is the new headquarters of Foundation Medicine, a biotechnology firm that is consolidating its 1,100 Massachusetts employees into a new 16-story brick masonry building at 400 Summer St. Foundation, established in 2010 and later acquired by the Swiss drug giant Roche, had workers scattered among four locations, including its former headquarters in Cambridge.

About 800 workers have moved into the 630,000-square-foot building, which is kitty-corner from the Boston Convention and Exhibition Center, with the remaining 300 expected to arrive by early next year. No one seems happier about the long-planned consolidation than Dan Malarek, a 17-year veteran of Roche who became Foundation’s chief executive in December.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： FDA approves Eli Lilly ulcerative colitis treatment Omvoh

WSS

FDA rejects Alnylam's heart disease treatment over insufficient data

FDA has safety concerns on CRISPR

The future of health care in the House

Chan Zuckerberg Biohub Chicago to focus on inflammation

Analysis of telehealth claims data suggest service duplication

Bristol 'take

entertainment

leisure time

knowledge

Medical leaders decry Supreme Court decision on affirmative action

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Activists slam private health insurers over coverage restrictions

AI can decode, harness the power of the humane immune system

At least 13 dead in Texas as scorching temps continue

Testing for cancer recurrence creates a new limbo for patients

Trump demands the U.S. pay no more for drugs than other countries … again

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Drug repurposing or repositioning? The language matters

Telehealth options flood the market as retailers push virtual care

explore

Chimpanzees, like humans and whales, get menopause: Study

VC firm General Catalyst wants to buy a health system

FDA authorizes Novavax’s updated Covid

Why Charlie Gard's case is so disturbing to Americans

Maker of FluMist seeks to allow at

Chemotherapy drug shortage eases slightly but still widespread

knowledge

leisure time

focus

leisure time